ArticleOphthalmology science2026
Simultaneous Segmentation of Geographic Atrophy in Longitudinally Acquired Fundus Autofluorescence Images.
Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Accurately measuring geographic atrophy (GA) progression in clinical trials is challenging, owing to its slow and variable nature. This study develops deep learning algorithms that can measure GA growth rates with improved accuracy and robustness, by performing automated annotation of pre-existing versus newly expanding GA regions, based on simultaneous grading of fundus autofluorescence (FAF) image pairs. Design: Retrospective analysis of data acquired in 2 independent prospective clinical trials (i.e., 830 images in AREDS2 [Age-Related Eye Disease Study 2] and 273 images in METformin for the MINimization of Geographic Atrophy Progression [METforMIN]). Participants: One hundred seventy-four AREDS2 and 44 METforMIN participants. Methods: A standard DeepLabV3+ (DL) segmentation model that automatically segments GA from a single FAF image (DeepLabV3+ Main Outcome Measures: Image pixel overlap (using precision, recall, and Dice), GA area, and GA growth rates were measured with manual contours as the gold standard. The study also quantified the effect of longitudinal alignment of images to GA growth measurements. Results: When compared to manual expert annotations, the DL Conclusions: The simultaneous segmentation of longitudinal FAF images yielded improvements in accuracy and robustness by maintaining the longitudinal consistency of measurements. Such improvements are critical to the translation of automatic algorithms and minimizing measurement variability to effectively assess clinical trial outcomes in GA. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.